When improving peripheral blood hyperglycemia, xagliptin can further restore the phosphorylation and activation levels of PI3K/Akt and participate in inhibiting inflammatory reactions [6,7,8,18]. The gene discussed is AKT1; the disease is Hyperglycemia.